World Journal of Endocrine Surgery

Register      Login

VOLUME 9 , ISSUE 2 ( May-August, 2017 ) > List of Articles

RESEARCH ARTICLE

Revisiting Types and Risk Factors for Thyroid Malignancy in a State Endemic of Iodine Deficiency Goiter

Mei W Wong,, Imisairi A Hadi,, Kamarul I Musa

Citation Information : Wong, MW, Hadi, IA, Musa KI. Revisiting Types and Risk Factors for Thyroid Malignancy in a State Endemic of Iodine Deficiency Goiter. World J Endoc Surg 2017; 9 (2):51-54.

DOI: 10.5005/jp-journals-10002-1210

License: CC BY 3.0

Published Online: 01-08-2017

Copyright Statement:  Copyright © 2017; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Introduction

We have realized that recent rise in incidence of thyroid malignancy is partly because of incidental findings of cancer after resection for benign goiters. Therefore, we aim to reanalyze risk factors for thyroid malignancy in those patients who underwent primary thyroid surgery at Breast and Endocrine Surgical Unit, Department of Surgery, Hospital Raja Perempuan Zainab II, Kota Bharu, Kelantan, Malaysia.

Materials and methods

Retrospective review in our database found 699 patients who had undergone thyroid surgeries between June 2007 and December 2014. According to the final histopathological report of resected specimen, these patients, operated for goiter, were divided into two groups: Thyroid malignancy group and nonmalignancy group. Logistic regression analysis was used to estimate the risk of age, duration and weight of resected specimen for having thyroid malignancy.

Results

The mean value for age was 43.5 years [standard deviation (SD) = 14.0); duration of neck swelling was 5.9 months (SD = 6.7); and weight of resected specimen was 157 gm (SD = 161.0). Around 26.9% cases had thyroid malignancy (n = 188), about 77.13% cases had papillary thyroid carcinoma and 17.6% had follicular thyroid carcinoma. Age associates with risk for malignancy (p < 0.001), but duration of neck swelling (p = 0.513) and weight of resected specimen (p = 0.955) do not relate with this. With an increase of 1 year of age, the odds to have thyroid malignancy increase for 2%. This is equivalent with 14.4% increase in cancer for every 5-year increase in age.

Conclusion

Our study has found that increasing age is the only associated factor for risk of thyroid malignancy. When managing elderly patients who has clinically benign goiter, differential diagnosis of thyroid cancer need be considered as well.

How to cite this article

Wong MW, Hadi IA, Musa KI. Revisiting Types and Risk Factors for Thyroid Malignancy in a State Endemic of Iodine Deficiency Goiter. World J Endoc Surg 2017;9(2):51-54.


  1. Malaysian National Cancer Registry Report 2007–2011 [Internet]. National Cancer Registry 2015. pp.228.
  2. SEER Cancer Statistics Review 1975-2012, National Cancer Institute. Available from: http://seer.cancer.gov/csr/1975_2012/.
  3. Iodine deficiency status and iodised salt consumption in Malaysia: findings from a national iodine deficiency disorders survey. Asia Pac J Clin Nutr 2010;19(4):578-585.
  4. Ministry of Health Malaysia: 20 (2003).
  5. The prevalence of endemic goitre in Kelantan, Malaysia. Med J Malaysia 1993 Mar;48(1):64-70.
  6. Spectrum of thyroid lesions in hospital Universiti Sains Malaysia over 11 years and a review of thyroid cancers in Malaysia. Asian Pac J of Cancer Prev 2009 Jan-Mar;10(1):87-90.
  7. Microscopic papillary thyroid cancer as an incidental finding in patients treated surgically for presumably benign thyroid disease. J Postgrad Med 2007 Jan-Mar;53(1):23-26.
  8. Cancer after thyroidectomy: a multi-institutional experience with 1,523 patients. J Am Coll Surg 2013 Apr;216(4):571-577.
  9. Male sex, single nodularity and young age are associated with the risk of finding a papillary thyroid cancer on fine-needle aspiration cytology in a large series of patients with nodular thyroid disease. Eur J Endocrinol 2010 Apr;162(4):763-770.
  10. Epidemiological characteristics of thyroid nodules and risk factors for malignant nodules: a retrospective study from 6,304 surgical cases. Chin Med J (Engl) 2014;127(12):2286-2292.
  11. Thyroid malignancy among goitrous thyroid lesions: a review of hospital-based studies in Malaysia and Myanmar. Singapore Med J 2012 Mar;53(3):159-163.
  12. Incidence of thyroid malignancy among goitrous thyroid lesions from the Sarawak General Hospital 2000–2004. Singapore Med J 2009 Jul;50(7):724-728.
  13. Toxic multinodular goiter in the elderly. J Endocrinol Invest 2002;25(Suppl 10):16-18.
  14. Iodine intake and incidence of thyroid cancer in Denmark. Clin Endocrinol (Oxf) 2006 Aug;65(2):229-233.
  15. Iodine supplementation in Sweden and regional trends in thyroid cancer incidence by histopathologic type. Int J Cancer 1996 Jan 3; 65(1):13-19.
  16. Endocrine cancer in Iran: based on cancer registry system. Indian J Cancer 2006 Apr-Jun;43(2):80-85.
  17. Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med 1992 Oct;93(4):363-369.
  18. Increasing incidence of thyroid cancer in Great Britain, 1976–2005: age–period–cohort analysis. J Epidemiol Community Health 2010 Sep;64(Suppl 1):A31.
  19. Thyroid cancer incidence in Brazil: an approach using polynomial models. J Epidemiol Community Health 2011 Aug; 65(Suppl 1): A179.
  20. Is age associated with risk of malignancy in thyroid cancer? Otolaryngol Head Neck Surg 2014 Nov;151(5):746-750.
  21. Papillary carcinoma of the thyroid in Japan: subclassification of common type and identification of low risk group. J Clin Pathol 2004 Oct;57(10):1041-1046.
  22. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab 2006 Nov;91(11):4295-4301.
  23. Incidental thyroid carcinoma in a large series of consecutive patients operated on for benign thyroid disease. ANZ J Surg 2006 Mar;76(3):123-126.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.